All In Biotech

Drug Trial Radar · NCT03079388

Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)

Randomized Control Trial of the Use of Supplementary Food and Measures to Control Inflammation in Malnourished Pregnant Women to Improve Birth Outcomes

Last checked: Nov 19, 2026Latest source record: Jan 7, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,489 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,489

Actual

Start

Feb 27, 2017

Primary completion

Sep 24, 2019

Study completion Feb 24, 2020

Sponsor

Lead sponsor
Washington University School of MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Children's Investment Fund Foundation
First posted
Mar 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Acute malnutrition in pregnancy is a risk factor for adverse outcomes in mothers and their unborn children. Undernutrition during pregnancy can result in maternal complications such as life-threatening hemorrhage and hypertensive disorders of pregnancy and infant complications such as intrauterine growth retardation, low birth weight, pre-term delivery and poor cognitive development. Poor women in the developing world are at heightened risk of malnutrition due to inadequate dietary intake and are subject to transmission of a number of infections including malaria, intestinal helminths, and genitourinary infections. Food interventions for malnutrition may be less effective under conditions with excessive inflammation and infection, and especially so during pregnancy. Without specifically addressing treatment for infections, undernourished mothers may be less responsive to nutritional interventions. The benefits of treating both malnutrition and common infections simultaneously remain largely unstudied. This study tests the hypothesis that malnourished pregnant women receiving 100 grams per day of a specially formulated ready-to-use supplementary food in addition to a combination of 5 anti-infective interventions will have greater weight gain in pregnancy and deliver larger, longer infants than women receiving the standard of care. The outcome of the pregnancy and maternal nutritional status will be followed until 6 months after delivery.

Conditions

  • Pregnancy
  • Malnutrition in Pregnancy
  • Nutrition Disorders
  • Stunting

Interventions

  • Ready-to-use-supplementary foodDietary supplement

    Specially formulated supplementary food for pregnancy

  • Corn-soy-blendDietary supplement

    Standard of care for malnutrition in pregnancy in Sierra Leone

  • Monthly intermittent preventive treatment of malaria during pregnancy (IPTp)Drug

    Sulfadoxine-pyrimethamine (500 mg / 25 mg) given every 4 weeks, beginning at enrollment or at 13 weeks' gestation, whichever is later.

  • Standard intermittent preventive treatment of malaria during pregnancy (IPTp)Drug

    Standard of care for Sierra Leone is 2 doses of sulfadoxine/ pyrimethamine (500mg/ 25mg).

  • Insecticide-treated mosquito netOther

    An insecticide-treated mosquito net at the time of enrollment into the study.

  • AzithromycinDrug

    Azithromycin 1 gram given once in second trimester and again during weeks 28-34 of gestation.

  • AlbendazoleDrug

    Single dose albendazole 400mg given in the second trimester.

  • Bacterial vaginosis testing and treatmentCombination product

    Testing for bacterial vaginosis at enrollment and again at weeks 28-34 using a rapid diagnostic test for sialidase. Those with positive tests will receive extended release metronidazole 750mg daily for 7 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infant birth lengthTime frame: up to 40 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • 1 Moriba Street

    Pujehun, Pujehun District, Sierra Leone

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.